{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1381418520303772672.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Rachel Damico"}],"foaf:familyName":[{"@value":"Damico"}],"foaf:givenName":[{"@value":"Rachel"}]}],"career":[{"institution":{"notation":[{"@value":"Division of Pulmonary and Critical Care Medicine and"}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1361418520303772672","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1164/rccm.201507-1398oc"},{"@type":"URI","@value":"https://www.atsjournals.org/doi/pdf/10.1164/rccm.201507-1398OC"}],"notation":[{"@value":"Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1164/rccm.201507-1398oc_20lddSo4FfACVhGCp7bziI8Xqph"}]}